RICCERI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.185
EU - Europa 624
AS - Asia 578
SA - Sud America 64
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 14
OC - Oceania 9
Totale 2.494
Nazione #
US - Stati Uniti d'America 1.155
IT - Italia 229
RU - Federazione Russa 180
SG - Singapore 135
CN - Cina 132
BD - Bangladesh 100
SE - Svezia 69
VN - Vietnam 59
BR - Brasile 52
HK - Hong Kong 39
DE - Germania 37
IE - Irlanda 37
KR - Corea 34
JP - Giappone 22
CA - Canada 20
FR - Francia 20
FI - Finlandia 18
GB - Regno Unito 16
JO - Giordania 14
IN - India 12
TR - Turchia 11
AU - Australia 9
NL - Olanda 6
IQ - Iraq 4
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
JM - Giamaica 3
MX - Messico 3
PK - Pakistan 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AL - Albania 2
AR - Argentina 2
BE - Belgio 2
CL - Cile 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
SC - Seychelles 2
VE - Venezuela 2
BB - Barbados 1
CI - Costa d'Avorio 1
CO - Colombia 1
DO - Repubblica Dominicana 1
ES - Italia 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PL - Polonia 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
Totale 2.474
Città #
Santa Clara 173
Ashburn 161
Fairfield 94
Singapore 86
Chandler 64
Woodbridge 62
Seattle 51
Houston 48
Council Bluffs 44
San Jose 44
Milan 39
Dublin 37
Cambridge 34
Seoul 33
Buffalo 32
Hong Kong 31
Rome 30
Wilmington 29
Hefei 22
Tokyo 22
Los Angeles 21
Beijing 20
Altamura 19
Florence 19
Munich 19
New York 18
Ann Arbor 17
Lawrence 16
Ho Chi Minh City 13
The Dalles 13
Lauterbourg 12
Jacksonville 10
Princeton 9
Boardman 8
Boston 8
Dallas 8
Hanoi 8
Naples 8
Izmir 7
Turin 7
Turku 7
Da Nang 6
Genoa 6
Melbourne 6
Shanghai 6
Hillsboro 5
Palermo 5
San Diego 5
Toronto 5
Bengaluru 4
Cagliari 4
Chicago 4
London 4
Paris 4
Amsterdam 3
Atlanta 3
Brasília 3
Brescia 3
Brooklyn 3
Catania 3
Frankfurt am Main 3
Helsinki 3
Johannesburg 3
Kent 3
Montreal 3
Moscow 3
Mumbai 3
Norwalk 3
Orem 3
Padua 3
Pescara 3
Reggio Emilia 3
Tashkent 3
Tianjin 3
Bari 2
Bern 2
Brampton 2
Brussels 2
Campinas 2
Cento 2
Charlotte 2
Erbil 2
Falkenstein 2
Figino 2
Hortolândia 2
Hải Dương 2
Kingston 2
Mascalucia 2
Medford 2
Miano 2
Milwaukee 2
Neumarkt 2
Ottawa 2
Perugia 2
Porcari 2
Rio de Janeiro 2
São Paulo 2
Thái Nguyên 2
Tirana 2
Venice 2
Totale 1.579
Nome #
Atopic dermatitis. 233
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. 229
The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. 209
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 206
Psoriasis and body mass index. 194
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. 193
Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis. 165
Photodynamic treatment for viral infections of the skin. 161
NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis 152
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits 117
Treatment of severe nail psoriasis with acitretin: An impressive therapeutic result 94
Therapy of PsO in Special Subsets of Patients 89
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study 82
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 60
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 50
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 36
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 30
Age affects drug survival rates of interleukin (IL)‐17 and IL‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study 26
Risankizumab in very elderly patients in real-world practice 24
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study 24
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 19
Gottron papules: a pathognomonic sign of dermatomyositis 18
Etanercept therapy in a hepatitis B virus (HBV)‐positive psoriatic patient developing a monoclonal gammopathy of undetermined significance 16
Etanercept restores a differentiated keratinocyte phenotype in psoriatic human skin: a morphological study 16
Successful use of anti‐IL ‐23 molecules in overweight‐to‐obese psoriatic patients: A multicentric retrospective study 15
Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis 13
Induction of apoptosis by fractional CO 2 laser treatment 13
Reply 10
Totale 2.494
Categoria #
all - tutte 6.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202268 0 4 16 1 1 1 2 8 1 0 20 14
2022/2023225 16 56 9 22 20 33 20 8 31 3 3 4
2023/202460 2 8 11 3 4 13 4 6 1 1 5 2
2024/2025508 25 44 27 65 145 78 15 21 29 7 30 22
2025/20261.124 87 93 62 26 102 23 72 37 159 120 78 265
2026/202777 40 37 0 0 0 0 0 0 0 0 0 0
Totale 2.494